Tracking of secretory phospholipase A2 enzyme activity levels from childhood to adulthood: a 21-year cohort

Tracking of secretory phospholipase A2 enzyme activity levels from childhood to adulthood: a 21-year cohort

Show other versions (1)

Objective: Secretory phospholipase A2 (sPLA2) enzyme activity is a potential inflammatory biomarker for cardiovascular disease. We examined the tracking, or persistence, of sPLA2 enzyme activity levels from childhood to adulthood, and identify potentially modifiable factors affecting tracking. Metho...

Full description

Bibliographic Details
Main Authors:	Olivia Chung, Markus Juonala, Ziad Mallat, Nina Hutri-Kähönen, Jorma S.A. Viikari, Olli T. Raitakari, Costan G. Magnussen
Format:	Article
Language:	English
Published:	Elsevier 2019-03-01
Series:	Jornal de Pediatria
Online Access:	http://www.sciencedirect.com/science/article/pii/S0021755717311683

Similar Items

Tracking of secretory phospholipase A2 enzyme activity levels from childhood to adulthood: a 21‐year cohort
by: Olivia Chung, et al.
Published: (2019-03-01)

The Combined Effect of Common Genetic Risk Variants on Circulating Lipoproteins Is Evident in Childhood: A Longitudinal Analysis of the Cardiovascular Risk in Young Finns Study.
by: Marie-jeanne Buscot, et al.
Published: (2016-01-01)

Changes in Daily Steps and Body Mass Index and Waist to Height Ratio during Four Year Follow-Up in Adults: Cardiovascular Risk in Young Finns Study
by: Kasper Salin, et al.
Published: (2017-09-01)

Smoking and Physical Activity Trajectories from Childhood to Midlife
by: Kasper Salin, et al.
Published: (2019-03-01)

Bayesian hierarchical piecewise regression models: a tool to detect trajectory divergence between groups in long-term observational studies
by: Marie-jeanne Buscot, et al.
Published: (2017-06-01)

New evidence from plasma ceramides links apoE polymorphism to greater risk of coronary artery disease in Finnish adults[S]
by: Juho-Pekka Karjalainen, et al.
Published: (2019-09-01)

Effects of childhood and adolescence physical activity patterns on psychosis risk—a general population cohort study
by: Elina Sormunen, et al.
Published: (2017-01-01)

Associations Between Early Childcare Environment and Different Aspects of Adulthood Sociability: The 32-Year Prospective Young Finns Study
by: Elli Oksman, et al.
Published: (2019-09-01)

Modular genome-wide gene expression architecture shared by early traits of osteoporosis and atherosclerosis in the Young Finns Study
by: Binisha H. Mishra, et al.
Published: (2021-03-01)

A genome-wide association study identifies UGT1A1 as a regulator of serum cell-free DNA in young adults: The Cardiovascular Risk in Young Finns Study.
by: Juulia Jylhävä, et al.
Published: (2012-01-01)

<b>No Association of nineteen</b><it>COX-2</it><b> gene variants to preclinical markers of atherosclerosis The Cardiovascular Risk in Young Finns Study</b>
by: Lähteelä Kati, et al.
Published: (2012-07-01)

Adulthood blood levels of hsa-miR-29b-3p associate with preterm birth and adult metabolic and cognitive health
by: Saara Marttila, et al.
Published: (2021-04-01)

Type II secretory phospholipase A2 and prognosis in patients with stable coronary heart disease: mendelian randomization study.
by: Lutz P Breitling, et al.
Published: (2011-01-01)

Secretory Phospholipases A2 in Plants
by: María Elisa Mariani, et al.
Published: (2019-07-01)

Relations of APOE promoter polymorphisms to LDL cholesterol and markers of subclinical atherosclerosis in young adults
by: Leena E. Viiri, et al.
Published: (2006-06-01)

Achievement of the Targets of the 20-Year Infancy-Onset Dietary Intervention—Association with Metabolic Profile from Childhood to Adulthood
by: Miia Lehtovirta, et al.
Published: (2021-02-01)

The biomarker and causal roles of homoarginine in the development of cardiometabolic diseases: an observational and Mendelian randomization analysis
by: Ilkka Seppälä, et al.
Published: (2017-04-01)

Secretory Phospholipase A2s in Insulin Resistance and Metabolism
by: Michael S. Kuefner
Published: (2021-08-01)

Refolding, mutagenesis and characterisation of secretory phospholipase A2
by: Basran, Amrik
Published: (1996)

Life-course leisure-time physical activity trajectories in relation to health-related behaviors in adulthood: the Cardiovascular Risk in Young Finns study
by: Irinja Lounassalo, et al.
Published: (2021-03-01)

A Longitudinal Multilevel Study of the “Social” Genotype and Diversity of the Phenotype
by: Elli Oksman, et al.
Published: (2018-10-01)

Reliability and Validity of a Life Course Passive Smoke Exposure Questionnaire in an Australian Cohort From Childhood to Adulthood
by: Chigozie Ezegbe, et al.
Published: (2021-03-01)

Mechanism Governing the Cellular Susceptibility to Secretory Phospholipase A2
by: Jensen, Lauren Blackburn
Published: (2004)

Mechanism(s) of activation of secretory phospholipase A2s in mouse keratinocytes
by: Bangyan Li-Stiles, et al.
Published: (1999-09-01)

Proteolysis sensitizes LDL particles to phospholipolysis by secretory phospholipase A2 group V and secretory sphingomyelinase
by: Riia Plihtari, et al.
Published: (2010-07-01)

Genetic variants and their interactions in the prediction of increased pre-clinical carotid atherosclerosis: the cardiovascular risk in young Finns study.
by: Sebastian Okser, et al.
Published: (2010-09-01)

Synergy between serum amyloid A and secretory phospholipase A2
by: Shobini Jayaraman, et al.
Published: (2019-05-01)

Evaluation of Rhamnetin as an Inhibitor of the Pharmacological Effect of Secretory Phospholipase A2
by: Mariana Novo Belchor, et al.
Published: (2017-08-01)

Secretory non-pancreatic phospholipase A2: influence on lipoprotein metabolism
by: F C de Beer, et al.
Published: (1997-11-01)

Income and Physical Activity among Adults: Evidence from Self-Reported and Pedometer-Based Physical Activity Measurements.
by: Jaana T Kari, et al.
Published: (2015-01-01)

Examining the effect of mitochondrial DNA variants on blood pressure in two Finnish cohorts
by: Jaakko Laaksonen, et al.
Published: (2021-01-01)

Mechanisms by Which Apoptotic Membranes Become Susceptible to Secretory Phospholipase A2
by: Bailey, Rachel Williams
Published: (2008)

Secretory Phospholipase A2 Tipe II (SPLA II) In Cardiovascular Disease
by: Djanggan Sargowo
Published: (2015-11-01)

Secretory phospholipase A2 group IIA modulates insulin sensitivity and metabolism
by: Michael S. Kuefner, et al.
Published: (2017-09-01)

Genetic and functional studies of lipoprotein-associated phospholipase A2 and secretory phospholipase A2 variants : their potential role in atherosclerosis
by: Wootton, Peter Thomas Edward
Published: (2006)

Secretory breast carcinoma in adulthood: A case report with literature review
by: Ivković-Kapicl Tatjana, et al.
Published: (2020-01-01)

Group V Secretory Phospholipase A2 Is Involved in Tubular Integrity and Sodium Handling in the Kidney.
by: João Luiz Silva-Filho, et al.
Published: (2016-01-01)

Characterization of plasma secretory phospholipase A2 activity in the prairie rattlesnake (Crotalus viridis)
by: Sarah Baker, et al.
Published: (2020-06-01)

Secretory phospholipase A2 modified HDL rapidly and potently suppresses platelet activation
by: Sanja Curcic, et al.
Published: (2017-08-01)

Lactadherin inhibits secretory phospholipase A2 activity on pre-apoptotic leukemia cells.
by: Steffen Nyegaard, et al.
Published: (2013-01-01)

Cannot write session to /tmp/vufind_sessions/sess_snkrv0ljf0fe0o2lu39dnnj1da